Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Neuroone Medical Technologies (NMTC) over the last 8 years, with Q4 2025 value amounting to $359255.0.

  • Neuroone Medical Technologies' Share-based Compensation rose 590.49% to $359255.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 million, marking a year-over-year decrease of 657.59%. This contributed to the annual value of $1.3 million for FY2025, which is 594.05% down from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Share-based Compensation of $359255.0 as of Q4 2025, which was up 590.49% from $358560.0 recorded in Q3 2025.
  • Neuroone Medical Technologies' Share-based Compensation's 5-year high stood at $878852.0 during Q2 2021, with a 5-year trough of $203072.0 in Q4 2021.
  • Over the past 5 years, Neuroone Medical Technologies' median Share-based Compensation value was $312646.0 (recorded in 2023), while the average stood at $328418.9.
  • Per our database at Business Quant, Neuroone Medical Technologies' Share-based Compensation tumbled by 7092.25% in 2022 and then soared by 5017.51% in 2024.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Share-based Compensation stood at $203072.0 in 2021, then skyrocketed by 47.82% to $300181.0 in 2022, then rose by 2.82% to $308638.0 in 2023, then rose by 9.91% to $339224.0 in 2024, then increased by 5.9% to $359255.0 in 2025.
  • Its Share-based Compensation stands at $359255.0 for Q4 2025, versus $358560.0 for Q3 2025 and $316654.0 for Q2 2025.